Critical Alert: Blood Pressure Medication Recall Due to Dangerous Label Mix-Up
Health Canada has issued an urgent recall for specific lots of amlodipine, a common blood pressure medication, after discovering potentially life-threatening labeling errors. Reports indicate some bottles labeled as amlodipine (used for high blood pressure) actually contain nifedipine (used for low blood pressure).
This dangerous mix-up could lead to serious health consequences:
- Patients might receive incorrect dosages
- Risk of dangerous blood pressure fluctuations
- Potential medication interactions
Health authorities urge consumers to:
- Check medication labels for lot numbers A10333 or A10334
- Verify tablets match prescription descriptions
- Contact their pharmacist immediately if uncertain
The recall affects medications distributed through multiple provinces. Patients experiencing dizziness, fainting, or unusual symptoms should seek medical attention immediately. Always consult healthcare providers before stopping or changing medications.
This alert follows investigations by Health Canada and multiple media reports documenting the packaging error. Consumers should visit the Health Canada website for official recall notices and updated safety information.
